Introduction
As part of the ongoing war against drugs by the Department of Defense (DOD), a military working dog (MWD) program was established at Lackland Air Force Base, TX in 1990 to provide training for drug-detection dogs. This basic training for the dogs and their handlers requires the use of training aids. The training aids are ventilated canisters containing one of the common street drugs and are prepared exclusively by the Naval Criminal Investigative Service (NCIS) Regional Forensic Laboratory in Norfolk, VA.
Preparation of the training aids exposes laboratory personnel to street drugs on a recurring basis. As a consequence, the NCIS Regional Forensic Laboratory has monitored casual exposure to marijuana, hashish, heroin (6-acetylmorphine), cocaine, and methylenedioxymethamphetamine through an in-house urinalysis program. The Navy Drug Screening Laboratory (NDSL), Jacksonville, FL, has conducted urinalysis testing for the above samples since 1995.
Whether working in a forensic laboratory or in the field, law enforcement personnel are often exposed to drugs while handling drug evidence, and the possibility of a positive drug test due to on-the-job exposure is a definite concern (1--4). EISohly (1) examined this possibility with a single subject handling contaminated dollar bills and concluded that the handling of cocaine contaminated articles would not result in a positive benzoylecgonine (BZE) test at the Health and Human Services (HHS) immunoassay screening cutoff level of 300 ng/mL. However, Le et al. (3) observed high levels of BZE including one case where a 1570 ng/mL urine concentration was observed for an employee who sampled a 50-kg seizure of cocaine hydrochloride over a 3-h period.
In the study presented here, 233 human urine samples, collected between December 1999 and January 2001, were tested for the cocaine metabolite, benzoylecgonine, by gas chromatography-mass spectrometry (GC-MS). Urine samples were collected on days the cocaine training aids were in preparation, including the days preceding and following preparation. This is the first study to provide an assessment of exposure from the preparation of MWD training aids. Test results were evaluated with respect to concentration. Information on personal protective equipment (PPE) used during preparation and its effect on exposure are also examined.
Materials and Methods

Manufacture of training aids
The manufacture of the training aids was conducted as follows. Seized cocaine samples were ground with a mortar and pestle to remove clumps and achieve the desired texture prior to weighing. This process was performed in a fume hood. The technician performing this task wears a facemask, gloves, and lab coat. Once weighed into 1-, 2-, 3-, 5-, or 10-g quantities, the cocaine is poured into prefolded filter paper (Whatman #4) bindles and stapled.
A special 3-oz. tin seamless slipcover can (United States Can Co., Baltimore, MD) was used as the drug container. The can consists of two pieces with seven prepunched holes in each piece for ventilation of the cocaine odor. The containers are washed with unscented soap prior to use to remove any oil from the manufacturing process. After placement of the cocaine, the can is secured with lead disc seals.
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The author to whom correspondence should be addressed. E-mail: kklette@dlj0ndsl.med.navy.miL from each technician at the beginning of the shift, midshift, and at the end of the shift. The NCIS Regional Forensic Laboratory maintained the samples in a secured refrigerator until shipment via U.S. Mail. Batch sizes ranged from a few samples to approximately 30 samples. Upon arrival at NDSL, the shipping container was opened and transferred to a secured storage area. A chain-of-custody for the samples was maintained throughout testing.
Extraction of BZE BZE was extracted from urine using a previously described RapidTrace TM (Zymark, Hopkinton, MA) automated extraction system (5). The samples were assayed as a batch along with quantitation standards and positive and negative controls. BZE and the internal standard, 2H3-BZE, were extracted using a HCX cation-exchange resin in a solid-phase cartridge (Isolute, Glamorgan, U.K.). The analyte and internal standard were alkylated using 1-iodopropane (Acros, N J).
GC-MS procedure for BZE
Forensic identification of the cocaine metabolite was accomplished using retention time match and qualifying product ion ratios. Retention time match was considered acceptable if the samples and controls exhibited retention times within • 2% of the calibration standard. An Agilent 6890 GC coupled to a 5972 or 5973 MSD (Agilent, Palo Alto, CA) operated in electronimpact selected ion monitoring (EI-SIM) mode was used for the analysis. Three ions (m/z 210, 272, and 331) were monitored for the analyte and two ions (m/z 334 and 213) for the internal standard. The quantitation ratio (BZE/BZE-d3) was m/z 210/213, and the qualifiers for identification were the m/z 272/210 and 331/210 ratios. The qualifier ion ratio for the internal standard, BZE-d3, was m/z 334/213. BZE concentrations for samples and controls were determined by single-point calibration against the 100-ng/mL BZE calibrator using the m/z 210/213 BZE/BZE-d3 ion ratio.
Results and Discussion
Two hundred thirty-three urine samples were tested in the study. BZE was detected in 88 of the 233 samples. Results were obtained from urine samples collected from 13 laboratory employees either preparing the aids or working within the laboratory spaces. The employees included drug chemists, document examiners, evidence custodians, and a secretary. There were two samples above the DOD GC-MS cutoff of 100 ng/mL with concentrations of 460 and 138 ng/mL and a third sample that quantitated below the cutoff at 84 ng/mL. Notably, the 460-ng/mL sample would also be positive using the HHS cutoff of 150 ng/mL. The established laboratory limit of detection (LOD) was 12.5 ng/mL for the Agilent 5972/5973 GC-MS. Thirty-five samples quantitated above the LOD (15% of the 
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Below LOD with BZE ions samples tested). Fifty-three samples (23%) were below the LOD but had detectable levels of BZE (Figure 1) . The testing results are summarized in Tables I and II. Table  I provides a complete listing of samples containing BZE. There * Samples with detectable BZE ions but below the limit of detection (LOD). ~" Samples with quantitations above the LOD but with "ratios out" (ro).
were 28 samples with quantitations above the LOD. Another seven samples quantitated above the LOD but had qualifying ion ratios that exceeded the + 20 range established by the calibrator (ratio out [ro]). Samples denoted by an asterisk (*) were below the LOD but exhibited the three characteristic ions of BZE. In Table II , samples above 30 ng/mL are listed along with PPE used by the technician during preparation. The samples with the highest concentration of BZE were observed on 2/4/00, 3/29/00, tl/16/00, and 11/17/00. The two highest (2/4/00) were collected from different technicians at approximately 2:30 p.m. The technicians that provided these samples, 138 ng/mL and 460 ng/mL, also had detectable levels of BZE in their urine at the beginning of the shift or approximately 7:00 a.m. (Samples 5 and 6, respectively). Samples 5 and 6 had BZE concentrations of 27 ng/mL (ro) and 26 ng/mL, respectively. Throughout the study, 31 samples collected at the beginning of the shift (6:30 to 7:00 a.m.) contained BZE. Concentrations ranged from 3 to 53 ng/mL; 19 of 31 were less than the LOD. During preparation of the training aids, laboratory personnel were exposed to both dermal and airborne contact. In most instances, laboratory personnel used gloves, masks, and lab coats, but conclusions cannot be drawn regarding the use of PPE and exposure. Further examination of preparation technique, number of aids prepared, and laboratory conditions revealed no differences that would account for the higher BZE concentrations on some days.
Controlled experiments will be needed to identify the primary source of the exposure. Based on data presented here, there were no apparent trends in the concentration data, and use or nonuse of personal protective equipment could not be correlated with higher BZE concentrations. Further complicating interpretation, some urine samples collected at the beginning of a shift contained detectable levels of BZE. Despite the lack of cor- relation, the results demonstrate that a laboratory worker can test positive for BZE at both HHS and DOD cutoff levels through incidental exposure. The identification of two positive samples and detection of BZE in 38% of the samples are significant. Legal issues could arise for laboratory employees participating in a military or DOD civilian drug-testing program. Further investigation is needed. Planned studies will include the use of control groups and laboratory air sampling in identifying relationships between the use of PPE, preparation procedures, and urine BZE concentration. This planned study should identify problem areas and help to minimize exposure to laboratory personnel.
